Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson's disease.
Saved in:
| Title: | Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson's disease. |
|---|---|
| Authors: | Miller SJ; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, United States., Darji RY; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, United States., Walaieh S; Department of Biology, Eastern Nazarene College, Quincy, MA, United States., Lewis JA; Department of Biology, Eastern Nazarene College, Quincy, MA, United States., Logan R; Department of Biology, Eastern Nazarene College, Quincy, MA, United States. |
| Source: | Frontiers in neurology [Front Neurol] 2023 Sep 28; Vol. 14, pp. 1271941. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-2295 |
|---|---|
| DOI: | 10.3389/fneur.2023.1271941 |
